Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Bacterium or component thereof or substance produced by said...
Patent
1991-09-06
1998-03-10
Cunningham, Thomas M.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Bacterium or component thereof or substance produced by said...
4241851, 530350, 5303895, 530412, 530825, A61K 39118, C07K 14295
Patent
active
057258635
ABSTRACT:
The present invention relates to a polypeptide vaccine and method to immunize subjects against Chlamydia. In particular, this invention relates to essentially pure polypeptides of Chlamydia psittaci strain DD-34 ranging from about 40 to 140 kilodaltons in a pharmaceutically acceptable carrier. These compositions are used to immunize several species of animals against Chlamydia. More specifically, this invention relates to the discovery of a highly immunogenic essentially pure polypeptide of Chlamydia psittaci strain DD-34 having a molecular weight of about 96 kilodaltons.
REFERENCES:
patent: 4118469 (1978-10-01), Caldwell et al.
patent: 4267170 (1981-05-01), Seawell
patent: 4271146 (1981-06-01), Seawell
patent: 4386065 (1983-05-01), Waldhalm
patent: 4427782 (1984-01-01), Caldwell et al.
patent: 4497899 (1985-02-01), Armstrong et al.
patent: 4663291 (1987-05-01), Rose
patent: 4766065 (1988-08-01), Mosier et al.
patent: 4916057 (1990-04-01), Thompson et al.
Anderson et al., Efficacy Against Ovine Enzootic Abortin of an Experimental Vaccine Containing Purified Elementary Bodies of Chlamydia psittaci, Veterinary Microbiology 24:21-27 (1990).
Baehr et al, Mapping Antigenic Domains Expressed by Chlamydia trachomatis Major Outer Membrane Protein Genes, Proc. Natl. Acad. Sci U.S.A. 85:4000-4004 (1988).
Baghian et al, Antibody Response to Epitopes of Chlamydial Major Outer Membrane Proteins on Infectious Elementary Bodies and of the Reduced Polyacrylamide Gel Electrophoresis-Separated Form, Infection and Immunity 58:1379-1383 (1990).
U.S. application No. 07/324,664, Caldwell et al., filed Mar. 17, 1989.
Barron, Microbiology of Chlamydia.
Batteiger et al., Antigenic Analysis of the Major Outer Membrane Protein of Chlamydia trachomatis with Murine Monoclonal Antibodies, Infectino and Immunity 53:530-533 (1986).
Bavoil et al., Role of Disulfide Bonding in Outer Membrane Structure and Permeability in Chlamydia trachomatis, Infection and Immunity 44:479-485 (1984).
Blobel et al., Chlamydia, Handbuch der Bakteriellen Infektionen bei Tieren, Band V. 447-531 (1985).
Brade et al., Chemical, Biological, and Innunochemical Properties of the Chlamydia psittaci Lipoplysaccharide, Infection and Immunity 54:568-574 (1986).
Caldwell et al., Antigen Analysis of the Major Outer Membrane Protein of Chlamydia spp., Infection and Immunity 35:1024-1031 (1982).
Caldwell et al., Structural Analysis of Chlamydial Major Outer Membrane Proteins, Infection and Immunity 38:960-968 (1982).
Carlson et al., Cloning and Characterization of a Chlamydia trachomatis L3 DNA Fragment That Codes for an Antigenic Region of the Major Outer Membrane Protein and Specifically Hybridizes to the C-and C-Related-Complex Serovars, Infection and Immunity 57:487-494 (1989).
Chandler et al. I, A New Enzyme Immunoassay System Suitable for Field Use and Its Application in a Snake Venom Detection Kit, Clinica Chimica Acta 121:225-230 (1982).
Chandler et al. II, An Investigation of the Use of Urease-Antibody Conjugates in Enzyme Immunoassays, J. of Immunological Methods 53:187-194 (1982).
Conlan et al. I, Epitope Mapping with Solid-Phase Peptides: Identification of Type-, Subspecies-, Species-and Genus-Reactive Antibody Binding Domains on the Major Outer Membrane Protein of Chlamydia trachomatis, Molecular Microbiology 2(5):673-679 (1988).
Conlan et al. II, The major outer membrane protein of Chlamydia trachomatis: critical binding site and conformation determine the specificity of antibody binding to viable chlamydiae, Molecular Microbiology 3(3):311-318 (1989).
Dopfer et al., Vertraglichkeits-und immunisierungsversuche mit einer kommerziellen Vakzine gegen Chlamydia psittaci und Coxiella burnetii, Dtsch. tierarztl. Wschr. 93:267-269 (1986).
Favero, Biological Hazards in the Laboratory, Laboratory Medicine 18:665-670 (1987).
Filstein et al., Epidemic of Psittacosis in a College of Veterinary Medicine, JAVMA 179:569-572 (1981).
Fraiz et al., Chlamydial Infectios, Am. Rev. Med. 39:357-370 (1988).
Fudge, Update on Chlamydiosis, Veterinary Clinics of North America: Small Animal Practice 14:201-221 (1984).
Johnson et al. I, Abortion due to infection with Chlamydia psittaci in a sheep farmer's wife, British Medical Journal 290:592-595 (1985).
Johnson et al. II, Intracerebral Infection of Mice with Ovine Strains of Chlamydia psittaci: an Animal Screening Test for the Assay of Vaccines, J. Comp. Path. 96:497-505 (1986).
Kuo et al., Ultrascrutural Study of Chlamydia trachomatis Surface Antigens by Immunogold Staining with Monoclonal Antibodies, Infection and Immunity 55: 1324-1328 (1987).
Lagrange et al., Vaccines against Mycobacteria and Other Intracellular Multiplying Bacteria, Ann. Inst. Pasteur/Immunol. 136:151-162 (1985).
Larghi et al. I, Ethylenimine-Inactivated Rabies Vaccine of Tissue Culture Origin, J. Clin. Microbiology 3:26-33 (1967).
Larghi et al. II, Rabies Virus Inactivation by Binary Ethylenimine: New Method for Inactivated Vaccine Production, J. Clin. Microbiology 11:120-122 (1980).
Ma et al., Identification of conserved regions for species and subspecies specific epitopes on the major outer membrane protein of Chlamydia trachomatis, Microbial Pathogenesis 3:299-307 (1987).
MacDonald, Antigens of Chlamydia trachomatis, Reviews of Infectious Diseases 7:731-736 (1985).
Mahajan et al., Development of a Macromolecular Vaccine against Experimental Chlamydiosis and Berberine--a new anti-trachoma agent., 103-109 (1985).
Mohan, Epidemiologic and laboratory observations of Chlamydia psittaci infection in pet birds, JAVMA 184:1372-1374 (1984).
Moulder, The relation of the Psittacosis Group (Chlamydiae) to Bacteria and Viruses, Annual Review of Microbiology 20:107-130 (1966).
Nagington, Psittacosis/ornithosis in Cambridgeshire 1975-1983, J. Hyg., Camb. 92:9-19 (1984).
Nano et al., Partial Amino Acid Sequence and Molecular Cloning of the Encoding Gene for the Major Outer Membrane Protein of Chlamydia trachomatis, Infjection and Immunity 48:372-377 (1985).
Puy et al., Immunological specificity of monoclonal antibodies to Chlamydia psittaci ovine abortion strain, Immunology Letters 23:217-222 (1989/1990).
Rank et al., Protective Role of Serum Antibody in Immunity to Chlamydial Genital Infection, Infection Immunity 57:299-301 (1989).
Schachter, Overview of Chlamydia trachomatis Infection and the Requirements for a Vaccine, Reviews of Infectious Diseases 7:713-716 (1985).
Seki et al., Monoclonal Antibodies to Chlamydia psittaci: Characteristics and Antigenic Analysis, Jpn. J. Vet Sci. 50:383-393 (1988).
Smith et al., A modified ELISA that selectively detects monoclonal antibodies recognizing native antigen, J. of Immunological Methods 94:31-35 (1986).
Stephens et al. I, A species-specific major outer membrane protein domain, 110-113.
Stephens et al. II, High-Resolution Mapping of Serovar-Specific and Common Antigenic Determinants of the Major Outer Membrane Protein of Chlamydia trachomatis, J. Exp. Med. 167:817-831 (1988).
Storz, Chlamydia and Chlamydia-Induced Diseases (Charles C. Thomas Publishers 1971).
Su et al., Differential Effect of Trypsin on Infectivity of Chlamydia trachomatis: Loss of Infectivity Requires Cleavage of Major Outer Membrane Protein Variable Domains II and IV, Infection and Immunity 56:2094-2100 (1988).
Tan et al., Protection of Sheep against Chlamydia psittaci Infection with a Subcellular Vaccine Containing the Major Outer Membrane Protein, Infection and Immunity 58:3101-3108 (1990).
Taylor et al. I, Attempted Oral Immunization with Chlamydial Lipopolysaccharide Subunit Vaccine, Investigative Ophthalmology & Visual Science 28:1722-1726 (1987).
Taylor et al. II, Oral Immunization with Chlamydial Major Outer Membrane Protein (MOMP), Investigative Ophthalmology & Visual Science 29:1847-1853 (1988).
Toyofuku et al., Monoclonal Antibodies against Chlamydia psittaci, Microbiol. Immunol. 30:945-955 (1986).
Wenman et al., Chlamydia trachomatis Elementary Bodies Possess Proteins which Bind to Eucaryotic Cell Membranes, J. Bacteriology 165:602-607 (1986).
Yung et al., Psittacosis--a review of 135 cases, The Medical Journal of Austr
Daniels Eddie K.
Woollen Neal E.
Cunningham Thomas M.
Fado John D.
Ribando Curtis P.
Silverstein M. Howard
The United States of America as represented by the Secretary of
LandOfFree
Polypeptides useful in prevention of chlamydia infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polypeptides useful in prevention of chlamydia infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polypeptides useful in prevention of chlamydia infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-137206